Evidence map›Paper›PMID 31999809›Full record

ArticlePLoS pathogens2020

MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2.

Mary K McCarthy, Glennys V Reynoso, Emma S Winkler, Matthias Mack, Michael S Diamond, Heather D Hickman, Thomas E Morrison

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Ly6CCell reports · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mary K McCarthyDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
Glennys V ReynosoViral Immunity and Pathogenesis Unit, Laboratory of Clinical Microbiology and Immunology, National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, United States of America.
Emma S WinklerDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Matthias MackRegensburg University Medical Center, Regensburg, Germany.
Michael S DiamondDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America.
Heather D HickmanViral Immunity and Pathogenesis Unit, Laboratory of Clinical Microbiology and Immunology, National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, United States of America.ORCID 0000-0003-4168-4894
Thomas E MorrisonDepartment of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.ORCID 0000-0002-1811-2938
National Institute of Allergy and Infectious Diseases · USUniversity of Colorado Denver · USWashington University in St. Louis · US

Funding

Project 4 - Influenza - UABU19AI142759 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WHITLEY, RICHARD J. · 2019 to 2023
$37.5M
Screening CoreU19AI109680 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WHITLEY, RICHARD J. · 2014 to 2018
$34.9M
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
Imaging Antiviral ImmunityZIAAI001225 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HICKMAN, HEATHER · 2017 to 2025
$11.4M
Antibody Based Therapeuticcs for Chikungunya VirusR01AI089591 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S · 2010 to 2014
$4.7M
Structural and functional basis of ultra potent CHKV neutralization by human mAbsR01AI114816 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CROWE, JAMES E, DIAMOND, MICHAEL S · 2015 to 2019
$3.7M
Impairment of B cell Responses by Pathogenic Chikungunya VirusesR01AI141436 · NIAID · UNIVERSITY OF COLORADO DENVER · PI DIAMOND, MICHAEL S, MORRISON, THOMAS E · 2019 to 2023
$3.2M
IFN Dependent Control of Acute and Chronic Chikungunya Virus Induced DiseaseR01AI127513 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, LENSCHOW, DEBORAH J · 2017 to 2020
$2.1M
Mechanisms of adaptive immune suppression during pathogenic chikungunya virus infectionF32AI122463 · NIAID · UNIVERSITY OF COLORADO DENVER · PI MCCARTHY, MARY KATHERINE · 2016 to 2018
$174k
NIAID NIH HHS F32 AI122463NIAID NIH HHS R01 AI089591NIAID NIH HHS R01 AI114816NIAID NIH HHS R01 AI127513NIAID NIH HHS R01 AI141436NIAID NIH HHS T32 AI007163NIAID NIH HHS U19 AI109680NIAID NIH HHS U19 AI142759
6 · The paper itself

Abstract

Humoral immune responses initiate in the lymph node draining the site of viral infection (dLN). Some viruses subvert LN B cell activation; however, our knowledge of viral hindrance of B cell responses of important human pathogens is lacking. Here, we define mechanisms whereby chikungunya virus (CHIKV), a mosquito-transmitted RNA virus that causes outbreaks of acute and chronic arthritis in humans, hinders dLN antiviral B cell responses. Infection of WT mice with pathogenic, but not acutely cleared CHIKV, induced MyD88-dependent recruitment of monocytes and neutrophils to the dLN. Blocking this influx improved lymphocyte accumulation, dLN organization, and CHIKV-specific B cell responses. Both inducible nitric oxide synthase (iNOS) and the phagocyte NADPH oxidase (Nox2) contributed to impaired dLN organization and function. Infiltrating monocytes expressed iNOS through a local IRF5- and IFNAR1-dependent pathway that was partially TLR7-dependent. Together, our data suggest that pathogenic CHIKV triggers the influx and activation of monocytes and neutrophils in the dLN that impairs virus-specific B cell responses.

Indexed as

AnimalsB-LymphocytesChikungunya FeverChikungunya virusHumansInterferon Regulatory FactorsLymph NodesMice, Inbred C57BLMice, KnockoutMonocytesMyeloid Differentiation Factor 88NADPH Oxidase 2NeutrophilsNitric Oxide Synthase Type IICybb protein, mouseInterferon Regulatory FactorsIrf5 protein, mouseMyd88 protein, mouseMyeloid Differentiation Factor 88NADPH Oxidase 2Nitric Oxide Synthase Type IINos2 protein, mouse

Identifiers

PMID31999809
PMCPMC7012455
OpenAlexW3004219529

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.